Acasti Pharma`s (ACST) CEO Jan D`Alvise on Q2 2018 Results - Earnings Call Transcript
(WorldNews Health)

Acasti Pharma, Inc. (NASDAQ:ACST) Q2 2018 Earnings Conference Call November 14, 2018 11:00 AM ET Executives David Waldman - IR Jan D`Alvise - President and CEO Pierre Lemieux - Chief Operating Officer, Chief Scientific Officer and Co-Founder Brian Groach - Chief Commercial Officer Jean-François Boily - Vice President, Finance Analysts Operator Greetings and welcome to the Acasti Pharma Second Quarter 2019 Earnings Conference Call. [Operator Instructions]. I would now like to turn the conference over to David Waldman with Investor Relations. Please go ahead. David Waldman Thank you. Good morning everyone and welcome to Acasti Pharma second quarter conference call. On the call with us this...